Index by author

April 01, 1995; Volume 5,Issue 10

A

  1. Ahmad, H

    1. Aggressive, long-term cyclosporine therapy for steroid-resistant focal segmental glomerulosclerosis.
      E Ingulli, A Singh, N Baqi, H Ahmad, S Moazami and A Tejani
      JASN April 1995, 5 (10) 1820-1825; DOI: https://doi.org/10.1681/ASN.V5101820

  2. Alleyne, S

    1. Behavioral compliance with dialysis prescription in hemodialysis patients.
      P L Kimmel, R A Peterson, K L Weihs, S J Simmens, D H Boyle, D Verme, W O Umana, J H Veis, S Alleyne and I Cruz
      JASN April 1995, 5 (10) 1826-1834; DOI: https://doi.org/10.1681/ASN.V5101826

  3. Alvestrand, A

    1. Renal hemodynamics and sodium handling in moderate renal insufficiency: the role of insulin resistance and dyslipidemia.
      P Stenvinkel, A Ottosson-Seeberger and A Alvestrand
      JASN April 1995, 5 (10) 1751-1760; DOI: https://doi.org/10.1681/ASN.V5101751

  4. Andreoli, T E

    1. Presidential address. Personal views on health care issues.
      T E Andreoli
      JASN April 1995, 5 (10) 1725-1730; DOI: https://doi.org/10.1681/ASN.V5101725

  5. Atassi, N G

    1. Familial risk, age at onset, and cause of end-stage renal disease in white Americans.
      B J Spray, N G Atassi, A B Tuttle and B I Freedman
      JASN April 1995, 5 (10) 1806-1810; DOI: https://doi.org/10.1681/ASN.V5101806

  6. Atkins, M B

    1. Rapidly progressive glomerulonephritis after immunotherapy for cancer.
      M G Parker, M B Atkins, A A Ucci and A S Levey
      JASN April 1995, 5 (10) 1740-1744; DOI: https://doi.org/10.1681/ASN.V5101740

B

  1. Bain, R P

    1. The study of the effect of intensity of blood pressure management on the progression of type 1 diabetic nephropathy: study design and baseline patient characteristics. Collaborative Study Group.
      R A Rodby, R Rohde, J Evans, R P Bain, W S Mulcahy and E J Lewis
      JASN April 1995, 5 (10) 1775-1781; DOI: https://doi.org/10.1681/ASN.V5101775

  2. Baqi, N

    1. Aggressive, long-term cyclosporine therapy for steroid-resistant focal segmental glomerulosclerosis.
      E Ingulli, A Singh, N Baqi, H Ahmad, S Moazami and A Tejani
      JASN April 1995, 5 (10) 1820-1825; DOI: https://doi.org/10.1681/ASN.V5101820

  3. Becker, B N

    1. Intravenous immune globulin in the treatment of patients with systemic lupus erythematosus and end-stage renal disease.
      B N Becker, H Fuchs and R Hakim
      JASN April 1995, 5 (10) 1746-1750; DOI: https://doi.org/10.1681/ASN.V5101746

  4. Blantz, R C

    1. Renal hemodynamics and plasma and kidney angiotensin II in established diabetes mellitus in rats: effect of sodium and salt restriction.
      V Vallon, L M Wead and R C Blantz
      JASN April 1995, 5 (10) 1761-1767; DOI: https://doi.org/10.1681/ASN.V5101761

  5. Boyle, D H

    1. Behavioral compliance with dialysis prescription in hemodialysis patients.
      P L Kimmel, R A Peterson, K L Weihs, S J Simmens, D H Boyle, D Verme, W O Umana, J H Veis, S Alleyne and I Cruz
      JASN April 1995, 5 (10) 1826-1834; DOI: https://doi.org/10.1681/ASN.V5101826

  6. Brown, S A

    1. Impaired renal autoregulatory ability in dogs with reduced renal mass.
      S A Brown, D R Finco and L G Navar
      JASN April 1995, 5 (10) 1768-1774; DOI: https://doi.org/10.1681/ASN.V5101768

C

  1. Cruz, I

    1. Behavioral compliance with dialysis prescription in hemodialysis patients.
      P L Kimmel, R A Peterson, K L Weihs, S J Simmens, D H Boyle, D Verme, W O Umana, J H Veis, S Alleyne and I Cruz
      JASN April 1995, 5 (10) 1826-1834; DOI: https://doi.org/10.1681/ASN.V5101826

E

  1. Elger, M

    1. Structure-stabilizing forces in the glomerular tuft.
      W Kriz, M Elger, P Mundel and K V Lemley
      JASN April 1995, 5 (10) 1731-1739; DOI: https://doi.org/10.1681/ASN.V5101731

  2. Evans, J

    1. The study of the effect of intensity of blood pressure management on the progression of type 1 diabetic nephropathy: study design and baseline patient characteristics. Collaborative Study Group.
      R A Rodby, R Rohde, J Evans, R P Bain, W S Mulcahy and E J Lewis
      JASN April 1995, 5 (10) 1775-1781; DOI: https://doi.org/10.1681/ASN.V5101775

F

  1. Finco, D R

    1. Impaired renal autoregulatory ability in dogs with reduced renal mass.
      S A Brown, D R Finco and L G Navar
      JASN April 1995, 5 (10) 1768-1774; DOI: https://doi.org/10.1681/ASN.V5101768

  2. Finkelstein, F

    1. Comparison of continuous ambulatory peritoneal dialysis-related infections with different "Y-tubing" exchange systems.
      L Kiernan, A Kliger, N Gorban-Brennan, P Juergensen, D Tesin, E Vonesh and F Finkelstein
      JASN April 1995, 5 (10) 1835-1838; DOI: https://doi.org/10.1681/ASN.V5101835

  3. Freedman, B I

    1. Familial risk, age at onset, and cause of end-stage renal disease in white Americans.
      B J Spray, N G Atassi, A B Tuttle and B I Freedman
      JASN April 1995, 5 (10) 1806-1810; DOI: https://doi.org/10.1681/ASN.V5101806

  4. Friedlaender, M

    1. Insulin-like growth factor-1 (IGF-1) enhances recovery from HgCl2-induced acute renal failure: the effects on renal IGF-1, IGF-1 receptor, and IGF-binding protein-1 mRNA.
      M Friedlaender, M M Popovtzer, O Weiss, I Nefesh, J Kopolovic and I Raz
      JASN April 1995, 5 (10) 1782-1791; DOI: https://doi.org/10.1681/ASN.V5101782

  5. Fuchs, H

    1. Intravenous immune globulin in the treatment of patients with systemic lupus erythematosus and end-stage renal disease.
      B N Becker, H Fuchs and R Hakim
      JASN April 1995, 5 (10) 1746-1750; DOI: https://doi.org/10.1681/ASN.V5101746

G

  1. Gafter, U

    1. Modifications in glomerular polyanion distribution in adriamycin nephrosis.
      E Skutelsky, S Hartzan, R Socher and U Gafter
      JASN April 1995, 5 (10) 1799-1805; DOI: https://doi.org/10.1681/ASN.V5101799

  2. Gorban-Brennan, N

    1. Comparison of continuous ambulatory peritoneal dialysis-related infections with different "Y-tubing" exchange systems.
      L Kiernan, A Kliger, N Gorban-Brennan, P Juergensen, D Tesin, E Vonesh and F Finkelstein
      JASN April 1995, 5 (10) 1835-1838; DOI: https://doi.org/10.1681/ASN.V5101835

  3. Gretz, N

    1. The development of hypertension in the remnant kidney model after either pole resection or partial infarction of the kidney.
      N Gretz
      JASN April 1995, 5 (10) 1839-1840; DOI: https://doi.org/10.1681/ASN.V5101839

H

  1. Hakim, R

    1. Intravenous immune globulin in the treatment of patients with systemic lupus erythematosus and end-stage renal disease.
      B N Becker, H Fuchs and R Hakim
      JASN April 1995, 5 (10) 1746-1750; DOI: https://doi.org/10.1681/ASN.V5101746

  2. Hartzan, S

    1. Modifications in glomerular polyanion distribution in adriamycin nephrosis.
      E Skutelsky, S Hartzan, R Socher and U Gafter
      JASN April 1995, 5 (10) 1799-1805; DOI: https://doi.org/10.1681/ASN.V5101799

I

  1. Ingulli, E

    1. Aggressive, long-term cyclosporine therapy for steroid-resistant focal segmental glomerulosclerosis.
      E Ingulli, A Singh, N Baqi, H Ahmad, S Moazami and A Tejani
      JASN April 1995, 5 (10) 1820-1825; DOI: https://doi.org/10.1681/ASN.V5101820

J

  1. Juergensen, P

    1. Comparison of continuous ambulatory peritoneal dialysis-related infections with different "Y-tubing" exchange systems.
      L Kiernan, A Kliger, N Gorban-Brennan, P Juergensen, D Tesin, E Vonesh and F Finkelstein
      JASN April 1995, 5 (10) 1835-1838; DOI: https://doi.org/10.1681/ASN.V5101835

K

  1. Kiernan, L

    1. Comparison of continuous ambulatory peritoneal dialysis-related infections with different "Y-tubing" exchange systems.
      L Kiernan, A Kliger, N Gorban-Brennan, P Juergensen, D Tesin, E Vonesh and F Finkelstein
      JASN April 1995, 5 (10) 1835-1838; DOI: https://doi.org/10.1681/ASN.V5101835

  2. Kimmel, P L

    1. Behavioral compliance with dialysis prescription in hemodialysis patients.
      P L Kimmel, R A Peterson, K L Weihs, S J Simmens, D H Boyle, D Verme, W O Umana, J H Veis, S Alleyne and I Cruz
      JASN April 1995, 5 (10) 1826-1834; DOI: https://doi.org/10.1681/ASN.V5101826

  3. Kliger, A

    1. Comparison of continuous ambulatory peritoneal dialysis-related infections with different "Y-tubing" exchange systems.
      L Kiernan, A Kliger, N Gorban-Brennan, P Juergensen, D Tesin, E Vonesh and F Finkelstein
      JASN April 1995, 5 (10) 1835-1838; DOI: https://doi.org/10.1681/ASN.V5101835

  4. Kopolovic, J

    1. Insulin-like growth factor-1 (IGF-1) enhances recovery from HgCl2-induced acute renal failure: the effects on renal IGF-1, IGF-1 receptor, and IGF-binding protein-1 mRNA.
      M Friedlaender, M M Popovtzer, O Weiss, I Nefesh, J Kopolovic and I Raz
      JASN April 1995, 5 (10) 1782-1791; DOI: https://doi.org/10.1681/ASN.V5101782

  5. Kriz, W

    1. Structure-stabilizing forces in the glomerular tuft.
      W Kriz, M Elger, P Mundel and K V Lemley
      JASN April 1995, 5 (10) 1731-1739; DOI: https://doi.org/10.1681/ASN.V5101731

L

  1. Lemley, K V

    1. Structure-stabilizing forces in the glomerular tuft.
      W Kriz, M Elger, P Mundel and K V Lemley
      JASN April 1995, 5 (10) 1731-1739; DOI: https://doi.org/10.1681/ASN.V5101731

  2. Levey, A S

    1. Rapidly progressive glomerulonephritis after immunotherapy for cancer.
      M G Parker, M B Atkins, A A Ucci and A S Levey
      JASN April 1995, 5 (10) 1740-1744; DOI: https://doi.org/10.1681/ASN.V5101740

  3. Lewis, E J

    1. The study of the effect of intensity of blood pressure management on the progression of type 1 diabetic nephropathy: study design and baseline patient characteristics. Collaborative Study Group.
      R A Rodby, R Rohde, J Evans, R P Bain, W S Mulcahy and E J Lewis
      JASN April 1995, 5 (10) 1775-1781; DOI: https://doi.org/10.1681/ASN.V5101775

M

  1. Maesaka, J

    1. Dietary vitamin E supplementation ameliorates renal injury in chronic puromycin aminonucleoside nephropathy.
      H Trachtman, N Schwob, J Maesaka and E Valderrama
      JASN April 1995, 5 (10) 1811-1819; DOI: https://doi.org/10.1681/ASN.V5101811

  2. Moazami, S

    1. Aggressive, long-term cyclosporine therapy for steroid-resistant focal segmental glomerulosclerosis.
      E Ingulli, A Singh, N Baqi, H Ahmad, S Moazami and A Tejani
      JASN April 1995, 5 (10) 1820-1825; DOI: https://doi.org/10.1681/ASN.V5101820

  3. Mulcahy, W S

    1. The study of the effect of intensity of blood pressure management on the progression of type 1 diabetic nephropathy: study design and baseline patient characteristics. Collaborative Study Group.
      R A Rodby, R Rohde, J Evans, R P Bain, W S Mulcahy and E J Lewis
      JASN April 1995, 5 (10) 1775-1781; DOI: https://doi.org/10.1681/ASN.V5101775

  4. Mundel, P

    1. Structure-stabilizing forces in the glomerular tuft.
      W Kriz, M Elger, P Mundel and K V Lemley
      JASN April 1995, 5 (10) 1731-1739; DOI: https://doi.org/10.1681/ASN.V5101731

N

  1. Navar, L G

    1. Impaired renal autoregulatory ability in dogs with reduced renal mass.
      S A Brown, D R Finco and L G Navar
      JASN April 1995, 5 (10) 1768-1774; DOI: https://doi.org/10.1681/ASN.V5101768

  2. Nefesh, I

    1. Insulin-like growth factor-1 (IGF-1) enhances recovery from HgCl2-induced acute renal failure: the effects on renal IGF-1, IGF-1 receptor, and IGF-binding protein-1 mRNA.
      M Friedlaender, M M Popovtzer, O Weiss, I Nefesh, J Kopolovic and I Raz
      JASN April 1995, 5 (10) 1782-1791; DOI: https://doi.org/10.1681/ASN.V5101782

  3. Nissim, I

    1. Prostaglandin F2 alpha- and 12-O-tetradecanoylphorbol-13-acetate-induced alterations in the pathways of renal ammoniagenesis.
      A Sahai, I Nissim, R S Sandler and R L Tannen
      JASN April 1995, 5 (10) 1792-1798; DOI: https://doi.org/10.1681/ASN.V5101792

O

  1. Ottosson-Seeberger, A

    1. Renal hemodynamics and sodium handling in moderate renal insufficiency: the role of insulin resistance and dyslipidemia.
      P Stenvinkel, A Ottosson-Seeberger and A Alvestrand
      JASN April 1995, 5 (10) 1751-1760; DOI: https://doi.org/10.1681/ASN.V5101751

P

  1. Parker, M G

    1. Rapidly progressive glomerulonephritis after immunotherapy for cancer.
      M G Parker, M B Atkins, A A Ucci and A S Levey
      JASN April 1995, 5 (10) 1740-1744; DOI: https://doi.org/10.1681/ASN.V5101740

  2. Peterson, R A

    1. Behavioral compliance with dialysis prescription in hemodialysis patients.
      P L Kimmel, R A Peterson, K L Weihs, S J Simmens, D H Boyle, D Verme, W O Umana, J H Veis, S Alleyne and I Cruz
      JASN April 1995, 5 (10) 1826-1834; DOI: https://doi.org/10.1681/ASN.V5101826

  3. Popovtzer, M M

    1. Insulin-like growth factor-1 (IGF-1) enhances recovery from HgCl2-induced acute renal failure: the effects on renal IGF-1, IGF-1 receptor, and IGF-binding protein-1 mRNA.
      M Friedlaender, M M Popovtzer, O Weiss, I Nefesh, J Kopolovic and I Raz
      JASN April 1995, 5 (10) 1782-1791; DOI: https://doi.org/10.1681/ASN.V5101782

R

  1. Raz, I

    1. Insulin-like growth factor-1 (IGF-1) enhances recovery from HgCl2-induced acute renal failure: the effects on renal IGF-1, IGF-1 receptor, and IGF-binding protein-1 mRNA.
      M Friedlaender, M M Popovtzer, O Weiss, I Nefesh, J Kopolovic and I Raz
      JASN April 1995, 5 (10) 1782-1791; DOI: https://doi.org/10.1681/ASN.V5101782

  2. Rodby, R A

    1. The study of the effect of intensity of blood pressure management on the progression of type 1 diabetic nephropathy: study design and baseline patient characteristics. Collaborative Study Group.
      R A Rodby, R Rohde, J Evans, R P Bain, W S Mulcahy and E J Lewis
      JASN April 1995, 5 (10) 1775-1781; DOI: https://doi.org/10.1681/ASN.V5101775

  3. Rohde, R

    1. The study of the effect of intensity of blood pressure management on the progression of type 1 diabetic nephropathy: study design and baseline patient characteristics. Collaborative Study Group.
      R A Rodby, R Rohde, J Evans, R P Bain, W S Mulcahy and E J Lewis
      JASN April 1995, 5 (10) 1775-1781; DOI: https://doi.org/10.1681/ASN.V5101775

S

  1. Sahai, A

    1. Prostaglandin F2 alpha- and 12-O-tetradecanoylphorbol-13-acetate-induced alterations in the pathways of renal ammoniagenesis.
      A Sahai, I Nissim, R S Sandler and R L Tannen
      JASN April 1995, 5 (10) 1792-1798; DOI: https://doi.org/10.1681/ASN.V5101792

  2. Sandler, R S

    1. Prostaglandin F2 alpha- and 12-O-tetradecanoylphorbol-13-acetate-induced alterations in the pathways of renal ammoniagenesis.
      A Sahai, I Nissim, R S Sandler and R L Tannen
      JASN April 1995, 5 (10) 1792-1798; DOI: https://doi.org/10.1681/ASN.V5101792

  3. Schwob, N

    1. Dietary vitamin E supplementation ameliorates renal injury in chronic puromycin aminonucleoside nephropathy.
      H Trachtman, N Schwob, J Maesaka and E Valderrama
      JASN April 1995, 5 (10) 1811-1819; DOI: https://doi.org/10.1681/ASN.V5101811

  4. Simmens, S J

    1. Behavioral compliance with dialysis prescription in hemodialysis patients.
      P L Kimmel, R A Peterson, K L Weihs, S J Simmens, D H Boyle, D Verme, W O Umana, J H Veis, S Alleyne and I Cruz
      JASN April 1995, 5 (10) 1826-1834; DOI: https://doi.org/10.1681/ASN.V5101826

  5. Singh, A

    1. Aggressive, long-term cyclosporine therapy for steroid-resistant focal segmental glomerulosclerosis.
      E Ingulli, A Singh, N Baqi, H Ahmad, S Moazami and A Tejani
      JASN April 1995, 5 (10) 1820-1825; DOI: https://doi.org/10.1681/ASN.V5101820

  6. Skutelsky, E

    1. Modifications in glomerular polyanion distribution in adriamycin nephrosis.
      E Skutelsky, S Hartzan, R Socher and U Gafter
      JASN April 1995, 5 (10) 1799-1805; DOI: https://doi.org/10.1681/ASN.V5101799

  7. Socher, R

    1. Modifications in glomerular polyanion distribution in adriamycin nephrosis.
      E Skutelsky, S Hartzan, R Socher and U Gafter
      JASN April 1995, 5 (10) 1799-1805; DOI: https://doi.org/10.1681/ASN.V5101799

  8. Spray, B J

    1. Familial risk, age at onset, and cause of end-stage renal disease in white Americans.
      B J Spray, N G Atassi, A B Tuttle and B I Freedman
      JASN April 1995, 5 (10) 1806-1810; DOI: https://doi.org/10.1681/ASN.V5101806

  9. Stenvinkel, P

    1. Renal hemodynamics and sodium handling in moderate renal insufficiency: the role of insulin resistance and dyslipidemia.
      P Stenvinkel, A Ottosson-Seeberger and A Alvestrand
      JASN April 1995, 5 (10) 1751-1760; DOI: https://doi.org/10.1681/ASN.V5101751

T

  1. Tannen, R L

    1. Prostaglandin F2 alpha- and 12-O-tetradecanoylphorbol-13-acetate-induced alterations in the pathways of renal ammoniagenesis.
      A Sahai, I Nissim, R S Sandler and R L Tannen
      JASN April 1995, 5 (10) 1792-1798; DOI: https://doi.org/10.1681/ASN.V5101792

  2. Tejani, A

    1. Aggressive, long-term cyclosporine therapy for steroid-resistant focal segmental glomerulosclerosis.
      E Ingulli, A Singh, N Baqi, H Ahmad, S Moazami and A Tejani
      JASN April 1995, 5 (10) 1820-1825; DOI: https://doi.org/10.1681/ASN.V5101820

  3. Tesin, D

    1. Comparison of continuous ambulatory peritoneal dialysis-related infections with different "Y-tubing" exchange systems.
      L Kiernan, A Kliger, N Gorban-Brennan, P Juergensen, D Tesin, E Vonesh and F Finkelstein
      JASN April 1995, 5 (10) 1835-1838; DOI: https://doi.org/10.1681/ASN.V5101835

  4. Trachtman, H

    1. Dietary vitamin E supplementation ameliorates renal injury in chronic puromycin aminonucleoside nephropathy.
      H Trachtman, N Schwob, J Maesaka and E Valderrama
      JASN April 1995, 5 (10) 1811-1819; DOI: https://doi.org/10.1681/ASN.V5101811

  5. Tuttle, A B

    1. Familial risk, age at onset, and cause of end-stage renal disease in white Americans.
      B J Spray, N G Atassi, A B Tuttle and B I Freedman
      JASN April 1995, 5 (10) 1806-1810; DOI: https://doi.org/10.1681/ASN.V5101806

U

  1. Ucci, A A

    1. Rapidly progressive glomerulonephritis after immunotherapy for cancer.
      M G Parker, M B Atkins, A A Ucci and A S Levey
      JASN April 1995, 5 (10) 1740-1744; DOI: https://doi.org/10.1681/ASN.V5101740

  2. Umana, W O

    1. Behavioral compliance with dialysis prescription in hemodialysis patients.
      P L Kimmel, R A Peterson, K L Weihs, S J Simmens, D H Boyle, D Verme, W O Umana, J H Veis, S Alleyne and I Cruz
      JASN April 1995, 5 (10) 1826-1834; DOI: https://doi.org/10.1681/ASN.V5101826

V

  1. Valderrama, E

    1. Dietary vitamin E supplementation ameliorates renal injury in chronic puromycin aminonucleoside nephropathy.
      H Trachtman, N Schwob, J Maesaka and E Valderrama
      JASN April 1995, 5 (10) 1811-1819; DOI: https://doi.org/10.1681/ASN.V5101811

  2. Vallon, V

    1. Renal hemodynamics and plasma and kidney angiotensin II in established diabetes mellitus in rats: effect of sodium and salt restriction.
      V Vallon, L M Wead and R C Blantz
      JASN April 1995, 5 (10) 1761-1767; DOI: https://doi.org/10.1681/ASN.V5101761

  3. Veis, J H

    1. Behavioral compliance with dialysis prescription in hemodialysis patients.
      P L Kimmel, R A Peterson, K L Weihs, S J Simmens, D H Boyle, D Verme, W O Umana, J H Veis, S Alleyne and I Cruz
      JASN April 1995, 5 (10) 1826-1834; DOI: https://doi.org/10.1681/ASN.V5101826

  4. Verme, D

    1. Behavioral compliance with dialysis prescription in hemodialysis patients.
      P L Kimmel, R A Peterson, K L Weihs, S J Simmens, D H Boyle, D Verme, W O Umana, J H Veis, S Alleyne and I Cruz
      JASN April 1995, 5 (10) 1826-1834; DOI: https://doi.org/10.1681/ASN.V5101826

  5. Vonesh, E

    1. Comparison of continuous ambulatory peritoneal dialysis-related infections with different "Y-tubing" exchange systems.
      L Kiernan, A Kliger, N Gorban-Brennan, P Juergensen, D Tesin, E Vonesh and F Finkelstein
      JASN April 1995, 5 (10) 1835-1838; DOI: https://doi.org/10.1681/ASN.V5101835

W

  1. Wead, L M

    1. Renal hemodynamics and plasma and kidney angiotensin II in established diabetes mellitus in rats: effect of sodium and salt restriction.
      V Vallon, L M Wead and R C Blantz
      JASN April 1995, 5 (10) 1761-1767; DOI: https://doi.org/10.1681/ASN.V5101761

  2. Weihs, K L

    1. Behavioral compliance with dialysis prescription in hemodialysis patients.
      P L Kimmel, R A Peterson, K L Weihs, S J Simmens, D H Boyle, D Verme, W O Umana, J H Veis, S Alleyne and I Cruz
      JASN April 1995, 5 (10) 1826-1834; DOI: https://doi.org/10.1681/ASN.V5101826

  3. Weiss, O

    1. Insulin-like growth factor-1 (IGF-1) enhances recovery from HgCl2-induced acute renal failure: the effects on renal IGF-1, IGF-1 receptor, and IGF-binding protein-1 mRNA.
      M Friedlaender, M M Popovtzer, O Weiss, I Nefesh, J Kopolovic and I Raz
      JASN April 1995, 5 (10) 1782-1791; DOI: https://doi.org/10.1681/ASN.V5101782
Back to top

In this issue

View Selected Citations (0)